TORONTO, Oct. 3 /CNW/ - ClearScribe Inc. (www.clearscribe.com) announced
today it has signed an exclusive licensing agreement with Drugmagnet.ca
Holdings Limited, Canada's premier provider of mobile electronic prescription
technology and has closed a private round of financing to commercialize
Drugmagnet's regulatory-compliant technology.
The agreement provides for an exclusive intellectual property agreement
between the companies permitting modifications, sub-licensing and selling
agreements in North America and Europe.
ClearScribe is further pleased to announce that both Stephen Kahn,
founder of Drugmagnet and Rodney Dobson, founder and former President & CEO of
RxRite, a BlackBerry-based ePrescribing company, have joined the ClearScribe
Clear communication is the cornerstone of error prevention. When
healthcare professionals communicate effectively, there is a lower incidence
of error and a significant improvement in the overall quality of patient care.
It is well accepted that e-Prescribing has the greatest potential to eliminate
illegible, misread or misinterpreted prescriptions (e.g. sound alike drugs),
reduce adverse drug reactions, hospital admissions, deaths and unnecessary
costs that occur as a result of traditional prescribing practices ("...The
greatest impact on reducing medical errors would be to insist on electronic
prescription order entry..." Dr. Russell Ricci, General Manager, IBM Global
Healthcare). Implementing error reducing technology around the prescribing
process will improve patient safety and will alleviate some of the strain
placed on Canada's overburdened healthcare system reducing medication errors
("The Canadian Pharmacists Association estimates that 25% of hospital visits
by people over the age of 65 are due to medication errors" - Pharmacy Trends
Report, 2006). According to the Pharmacy Trends report, 79% of retail
pharmacists and 86% of hospital pharmacists support moving to e-scripts, so
that physicians can send prescriptions electronically.
"The momentum in the marketplace is clearly accelerating" said Rodney
Dobson, the newly appointed Director, of Channel Sales for ClearScribe. "After
seven years of research, technical development, beta projects, pilot studies
and the regulatory-compliant transmission of over 1,000,000 prescriptions, the
Drugmagnet technology is primed for the organized and rapid commercialization
by the ClearScribe team. We are already experiencing a marked increase in
opportunities for physician adoption and technology partnerships."
The desire of both Health Canada and provincial regulatory authorities to
implement regulatory-compliant tools that will reduce medication errors and
improve patient-safety set the stage for ClearScribe to leverage an increasing
base of electronic prescribing physicians in the commercialization of the
Drugmagnet technology. Drugmagnet's foundational technology permits
ClearScribe to deliver a superior regulatory-compliant electronic prescription
"We are delighted to add the Drugmagnet regulatory-compliant
point-of-care infrastructure technology to our suite of healthcare solutions,"
said Stephen Boston, President of ClearScribe."
The licensed mobile technology solutions offered through ClearScribe are
specifically designed to provide simple, affordable and efficient methods to
create and transmit prescription orders as well as receive medical information
via the ClearScribe Network. The ClearScribe Network is a robust
communications infrastructure comprised of data servers and communication
servers, web servers, Mail Exchange Servers, traditional DNS and dynamic DNS
Servers and ActiveFax servers. The ClearScribe network facilitates and manages
the secure and timely communication of sensitive healthcare information,
including prescription medication orders, laboratory results and critical
health warnings amongst members of the healthcare industry.
The technologies offered by ClearScribe permit participating physicians
and clinics to prepare, sign, fax and transmit patient prescriptions directly
to pharmacies. Benefits occur to the patient, the physician and the pharmacy
in terms of accuracy and patient safety.
In addition, ClearScribe's licensed technology platforms can be used to
transmit and receive other critical information between physicians, medical
laboratories and government health organizations.
For further information:
For further information: email@example.com, or www.clearscribe.com;
Stephen Kahn, Director - Channel Integration & Strategy, (416) 398-2866,
firstname.lastname@example.org; Rodney Dobson, Director - Channel Sales, (416)